Biostar Pharma Revenues Up $BSPM $XHS

Biostar Pharmaceuticals, Inc. has announced Fy-2014 Financial Results. The results shows the following:- Net sales increased by $8.7 million, or 16.5%, Cash and cash equivalents was $1.7 million at December 31, 2014 and Net income was $4.8 million; basic and diluted earnings per share was $0.33. View the full earnings release here.

Biostar Pharma Revenues Up $BSPM $XHS Read More »